CABDX
Price
$6.23
Change
+$0.02 (+0.32%)
Updated
Dec 23 closing price
RMFCX
Price
$54.97
Change
+$0.24 (+0.44%)
Updated
Dec 23 closing price
Ad is loading...

CABDX vs RMFCX

Header iconCABDX vs RMFCX Comparison
Open Charts CABDX vs RMFCXBanner chart's image
AB Relative Value A
Price$6.23
Change+$0.02 (+0.32%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.97
Change+$0.24 (+0.44%)
VolumeN/A
CapitalizationN/A
CABDX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CABDX vs. RMFCX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABDX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. CABDX (1.88B). RMFCX pays higher dividends than CABDX: RMFCX (1.69) vs CABDX (1.18). CABDX was incepted earlier than RMFCX: CABDX (93 years) vs RMFCX (23 years). CABDX is a more actively managed with annual turnover of: 77.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than CABDX: RMFCX (250) vs CABDX (2500). RMFCX annual gain was more profitable for investors over the last year : 11.11 vs. CABDX (3.61). RMFCX return over 5 years is better than : 37.80 vs. CABDX (16.28).
CABDXRMFCXCABDX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence93 years23 years-
Gain YTD2.7569.92128%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.88B102B2%
Annual Yield % from dividends1.181.6970%
Returns for 1 year3.6111.1132%
Returns for 3 years0.1212.381%
Returns for 5 years16.2837.8043%
Returns for 10 years20.8859.3635%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA